Option Care Health (NASDAQ:OPCH) Releases Earnings Results, Beats Expectations By $0.02 EPS

Option Care Health (NASDAQ:OPCH) posted its quarterly earnings data on Wednesday. The company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.02, Zacks reports. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%.

Option Care Health Stock Up 1.7 %

NASDAQ:OPCH traded up $0.54 during midday trading on Wednesday, hitting $33.17. 863,104 shares of the company were exchanged, compared to its average volume of 1,715,145. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $34.17. The company has a market capitalization of $5.65 billion, a PE ratio of 27.97, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a fifty day simple moving average of $28.07 and a 200 day simple moving average of $28.00.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of analyst reports. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research boosted their price target on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.